Healthcare - Biotechnology - NASDAQ - US
$ 63.42
-3.32 %
$ 12.1 B
Market Cap
38.91
P/E
Price Target
Average
53.96%
Revenue Forecast
Estimate
11.52%
EBIT
Estimate
--41.88%
Net Income
Estimate
60.39%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
BioMarin Pharmaceutical Inc.
Wall Street analysts predict an average 1-year price target for BMRN of $97.6 , with forecasts ranging from a low of $65 to a high of $122 .
BMRN Lowest Price Target
Wall Street Target
65 USD
2.49%
BMRN Average Price Target
Wall Street Target
97.6 USD
53.96%
BMRN Highest Price Target
Wall Street Target
122 USD
92.37%
REVENUE FORECAST
Revenue Forecast Chart BMRN
EBIT FORECAST
EBIT Forecast Chart BMRN
NET INCOME FORECAST
Net Income Chart BMRN